Information Provided By:
Fly News Breaks for April 3, 2018
AMED, LHCG, UNH, HUM, ANTM, AET
Apr 3, 2018 | 10:01 EDT
The Centers for Medicare and Medicaid Services' final notice for 2019 Medicare Advantage plans provides a 3.40% net increase in capitation rates and finalizes expanded coverage for non-skilled home health, along with other proposals, RBC analyst Frank Morgan tells investors in a research note. He believes the payment updates should be viewed positively for Managed Care stocks, and the expanded coverage of in-home services is a positive for Home Health stocks. Managed Care stocks include Aetna (AET), Anthem (ANTM), Humana (HUM) and UnitedHealth (UNH). Home Health stocks include LHC Group (LHCG) and Amedisys (AMED). Morgan notes that both companies have "built out significant personal care platforms."
News For AET;ANTM;HUM;UNH;LHCG;AMED From the Last 2 Days
UNH
Apr 19, 2024 | 04:50 EDT
Deutsche Bank analyst George Hill raised the firm's price target on UnitedHealth to $562 from $545 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat with many moving pieces caused by the cyberattack on Change Healthcare, which left earnings quality and guidance up to investor interpretation, the analyst tells investors in a research note. The firm sees the full impact of the hack, as well as conservatism around cost trend and utilization would impact UnitedHealth earnings by only 2% for the full year.
UNH
Apr 18, 2024 | 09:56 EDT
Notable gainers among liquid option names this morning include Genuine Parts (GPC) $159.09 +15.03, Globe Life (GL) $66.97 +3.74, Anthem (ELV) $532.10 +23.13, United Continental (UAL) $50.59 +1.84, and UnitedHealth (UNH) $494.80 +15.81.
UNH
Apr 18, 2024 | 09:41 EDT
Unusual total active option classes on open include: Wrap Technologies (WRAP), AstraZeneca (AZN), JetBlue (JBLU), United Continental (UAL), Taiwan Semi (TSM), Nokia (NOK), EBay (EBAY), Maplebear Inc (CART), Airbnb (ABNB), and UnitedHealth (UNH).
UNH
Apr 17, 2024 | 08:11 EDT
RBC Capital analyst Ben Hendrix lowered the firm's price target on UnitedHealth to $555 from $596 but keeps an Outperform rating on the shares. The company reported a "better than feared" Q1, but the debate over utilization trends is expected to persist through the first half as excess reserves skew the medical care ratio picture, the analyst tells investors in a research note. RBC also notes that its added caution reflects UnitedHealth's "reduced claims visibility".